References
- UNAIDS. Global Statistics Facts sheet. http://wwwunaidsorg/sites/default/files/media_asset/20150901_FactSheet_2015_enpdf. Accessed on January 23 2016. Google Scholar
- Liu C, Ostrow D, Detels R, Hu Z, Johnson L, Kingsley L et al. Impacts of HIV infection and HAART use on quality of life. Quality of Life Research. 2006;15(6):941-9. PubMed| Google Scholar
- Goosby E, Dybul M, Fauci A A, Fu J, Walsh T, Needle R et al. The United States President's Emergency Plan for AIDS Relief: a story of partnerships and smart investments to turn the tide of the global AIDS pandemic. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2012;60 Suppl 3:S51-S6. PubMed | Google Scholar
- Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased
acute myocardial infarction rates and cardiovascular
risk factors among patients with human immunodeficiency virus disease.
The Journal of Clinical
Endocrinology & Metabolism. 2007;92(7):2506-12. PubMed | Google
Scholar
- Mutimura E, Crowther N J, Stewart A, Todd Cade W. The human immunodeficiency virus and the cardiometabolic syndrome in the developing world: an African perspective. Journal of the cardiometabolic syndrome. 2008;3(2):106-10. PubMed | Google Scholar
- WHO GENEVA. Global Health estimates summary tables: Projection of deaths by cause, age and sex, by World Bank Income Group and WHO region 2013. http://wwwwhoint/healthinfo/global_burden_disease/en/. Accessed on October 12 2013. Google Scholar
- World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. World Health Organization. 2009. Google Scholar
- Dolan SE, Hadigan C, Killilea KM, Sullivan MP,
Hemphill L, Lees R S et al. Increased cardiovascular
disease risk indices in HIV-infected women. JAIDS Journal
of Acquired Immune Deficiency Syndromes.
2005;39(1):44-54. PubMed | Google
Scholar
- Lundgren JD, Battegay M, Behrens G, De Wit S, Guaraldi
G, Katlama C et al. European AIDS Clinical Society (EACS) guidelines
on the prevention and management of metabolic diseases in HIV. HIV medicine.
2008;9(2):72-81. PubMed | Google
Scholar
- Asiki G, Murphy GA, Baisley K, Nsubuga RN, Karabarinde
A, Newton R et al. Prevalence of dyslipidaemia and
associated risk factors in a rural population in South-Western Uganda:
a community based survey.
PLoS One. 2015;10(5):e0126166. PubMed | Google
Scholar
- Buchacz K, Weidle PJ, Moore D, Were W, Mermin J,
Downing R et al. Changes in lipid profile over 24 months among adults
on first-line highly active antiretroviral therapy in the home-based
AIDS care program in rural Uganda. JAIDS Journal of Acquired Immune Deficiency
Syndromes. 2008;47(3):304-11. PubMed | Google
Scholar
- Commission UA. HIV
and AIDS Uganda Country Progress Report 2013. Kampala: Uganda AIDS
Commission, 2014 Accessed on February 15 2016. Google
Scholar
- Uganda MoH. Addendum to the National Antiretroviral Treatment Guidelines for Uganda. 20 Accessed on March 21, 2016 at link; http://www.kisiizihospital.org.ug/wp-content/uploadedfiles/2013/10/Addednum-National-ART-Rx-Guidelines-Dec-20pdf. Google Scholar
- Gibb DM, Kizito H, Russell EC, Chidziva E, Zalwango
E, Nalumenya R et al. Pregnancy and infant outcomes
among HIV-infected women taking long-term ART with and without tenofovir
in the DART trial.
PLoS Med. 2012;9(5):e1001217. PubMed | Google
Scholar
- Kazooba P, Kasamba I, Baisley K, Mayanja B N, Maher D. Access to, and uptake of, antiretroviral therapy in a developing country with high HIV prevalence: a population-based cohort study in rural Uganda, 2004-2008. Tropical medicine & international health. 2012;17(8):e49-e57. PubMed | Google Scholar
- Organization WH. STEPwise approach to noncommunicable disease risk factor surveillance (STEPS). Geneva: World Health Organization. 2015. Google Scholar
- Murphy GA, Asiki G, Ekoru K, Nsubuga RN, Nakiyingi-Miiro
J, Young EH et al. Sociodemographic distribution of
non-communicable disease risk factors in rural Uganda:
a cross-sectional study. International
journal of epidemiology. 2013 Dec; 42 (6):1740-53. PubMed | Google
Scholar
- Alberti G, Zimmet P, Shaw J, Grundy SM. The IDF consensus worldwide definition of the metabolic syndrome. Brussels: International Diabetes Federation. 2006 May; 23 (5):469-80. PubMed | Google Scholar
- Expert Panel on Detection E. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Jama. 2001;285(19):2486. PubMed | Google Scholar
- James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb
C, Handler J et al. 2014 evidence-based guideline for
the management of high blood pressure in adults: report
from the panel members appointed
to the Eighth Joint National Committee (JNC 8). Jama.
2014;311(5):507-20. PubMed | Google
Scholar
- Mashinya F, Alberts M, Colebunders R. Assessment of cardiovascular risk factors in people with HIV infection treated with ART in rural South Africa: a cross sectional study. AIDS research and therapy. 2015;12(1):42. PubMed | Google Scholar
- Dobiássová M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapoB-lipoprotein-depleted plasma (FER HDL). Clinical biochemistry. 2001;34(7):583-8. PubMed | Google Scholar
- Payne R. The University of Edinburgh. Cardiovascular Risk Calculator. 2010;18:2014.. PubMed | Google Scholar
- Clark SJ, Gómez-Olivé FX, Houle B, Thorogood M,
Klipstein-Grobusch K, Angotti N et al. Cardiometabolic
disease risk and HIV status in rural South Africa: establishing a baseline.
BMC public
health. 2015;15(1):135. PubMed | Google
Scholar
- Sander LD, Newell K, Ssebbowa P, Serwadda D, Quinn
TC, Gray RH et al. Hypertension, cardiovascular risk
factors and antihypertensive medication utilisation
among HIV-infected individuals in Rakai, Uganda.
Tropical Medicine & International Health. 2015;20(3):391-6. PubMed | Google
Scholar
- Muyanja D, Muzoora C, Muyingo A, Muyindike W, Siedner M J. High prevalence of metabolic syndrome and cardiovascular disease risk among people With HIV on stable ART in Southwestern Uganda. AIDS patient care and STDs. 2016;30(1):4-10. PubMed | Google Scholar
- Dillon DG, Gurdasani D, Riha J, Ekoru K, Asiki
G, Mayanja BN et al. Association of HIV and ART with cardiometabolic
traits in sub-Saharan Africa: a systematic review and meta-analysis.
International journal of epidemiology. 2013;42(6):1754-71. PubMed | Google
Scholar
- Omech B, Sempa J, Castelnuovo B, Opio K, Otim M, Mayanja-Kizza H, et al. Prevalence of HIV-associated metabolic abnormalities among patients taking first-line antiretroviral therapy in Uganda. ISRN AIDS. 2012 Aug 23;2012:960178. PubMed | Google Scholar
- McCormick CL, Francis AM, Iliffe K, Webb H, Douch
CJ, Pakianathan M et al. Increasing Obesity in Treated
Female HIV Patients from Sub-Saharan Africa: Potential
Causes and Possible Targets for Intervention.
Frontiers in immunology. 2013;5:507. PubMed | Google
Scholar
- Lombo B, Alkhalil I, Golden M P, Fotjadhi I, Ravi S, Virata M et al. Prevalence of metabolic syndrome in patients with HIV in the era of highly active antiretroviral therapy. Conn Med. 2015;79(5):277-81. PubMed | Google Scholar
- Badiou S, De Boever CM, Dupuy A, Baillat V, Cristol
J, Reynes J. Decrease in LDL size in HIV-positive adults before and after
lopinavir/ritonavir-containing regimen: an index of atherogenicity. Atherosclerosis.
2003;168(1):107-13. PubMed | Google
Scholar
- Feeney ER, Mallon PW. HIV and HAART-associated
dyslipidemia. Open Cardiovascular Medicine Journal.
2011;5:49-63. PubMed | Google
Scholar
- Mateen F J, Kanters S, Kalyesubula R, Mukasa B, Kawuma E, Kengne AP et al. Hypertension prevalence and Framingham risk score stratification in a large HIV-positive cohort in Uganda. Journal of hypertension. 2013;31(7):1372-8. PubMed | Google Scholar
- Marma AK, Berry JD, Ning H, Persell SD, Lloyd-Jones
DM. Distribution of 10-year and lifetime predicted
risks for cardiovascular disease in US adults. Circ
Cardiovasc Qual Outcomes. 2010 Jan;3(1):8-14. PubMed | Google
Scholar
- Shaffer D, Hughes MD, Sawe F, Bao Y, Moses A, Hogg
E et al. Cardiovascular Disease Risk Factors in HIV-Infected Women Following
Initiation of Lopinavir/ritonavir-and Nevirapine-based Antiretroviral
Therapy in Sub-Saharan Africa: A5208 ("OCTANE"). Journal of acquired
immune deficiency syndromes (1999). 2014;66(2):155. PubMed | Google
Scholar
- Vittecoq D, Escaut L, Monsuez J. Vascular complications associated with use of HIV protease inhibitors. The Lancet. 1998;351(9120):1959. PubMed | Google Scholar
- Yone EWP, Betyoumin A F, Kengne A P, Folefack FJK,
Ngogang J. First-line antiretroviral therapy and dyslipidemia
in people living with HIV-1 in Cameroon: a cross-sectional
study. AIDS Research
and Therapy. 2011;8(1):33. PubMed | Google
Scholar
- Cook CB, Erdman DM, Ryan GJ, Greenlund KJ, Giles
WH, Gallina DL et al. The pattern of dyslipidemia
among urban African-Americans with type 2 diabetes.
Diabetes care. 2000;23(3):319-24. PubMed | Google
Scholar
- Onyedum CC, Young EE, Iroezindu MO, Chukwuka
CJ, Nwagha UI. Atherogenic index of plasma in highly
active antiretroviral therapy-naďve patients with human immunodeficiency
virus infection in Southeast Nigeria. Indian journal
of endocrinology and metabolism. 2014;18(5):631. PubMed | Google
Scholar
- Riha J, Karabarinde A, Ssenyomo G, Allender S, Asiki G, Kamali A et al. Urbanicity and lifestyle risk factors for cardiometabolic diseases in rural Uganda: a cross-sectional study. PLoS Med. 2014;11(7):e1001683. PubMed | Google Scholar
- Cohen B. Urbanization in developing countries:
Current trends, future projections, and key challenges
for sustainability. Technology in Society. 2006;28(1):63-80. Google
Scholar
- Constans J, Pellegrin J, Peuchant E, Thomas M, Dumon M, Sergeant C et al. Membrane fatty acids and blood antioxidants in 77 patients with HIV infection. La Revue de medecine interne/fondee par la Societe nationale francaise de medecine interne. 1992;14(10):1003. PubMed | Google Scholar